ÜIÜmit Übeyt Inan

Ümit Übeyt Inan

*This is an algorithmically generated author record based on publicly available information.

Ümit Übeyt Inan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reply

    by Ü Ü Inan, R G Sivaci, F Ozturk

  • Effects of fentanyl on pain and hemodynamic response after retrobulbar block in patients having phacoemulsification

    by Ümit Übeyt Inan, Remziye Gül Sivaci, Sıtkı Samet Ermis, Faruk Öztürk

    To determine the effects of systemic fentanyl analgesia in preventing the pain related to the administration of retrobulbar anesthesia and cataract surgery. Departments of Ophthalmology and Anesthesiology, School of Medicine, Kocatepe University, Afyon, Turkey. One hundred twenty patients with American Society of Anesthesiologists physical status I to III scheduled for cataract surgery were evaluated in a single-blind randomized study. Patients with a history of hypertension, hyperthyroidism, or neurologic or psychiatric disorders were excluded. In the study (fentanyl) group, an intravenous bolus of fentanyl 2 microg/kg was slowly given 5 minutes before retrobulbar anesthesia was administered. In the control group, fentanyl was not given. There were 60 patients in each group. Demographic data were not statistically different between the 2 groups. The intensity of pain during injection and intraoperatively was measured by verbal pain scores. Hemodynamic stability was assessed by the heart rate (HR) and mean arterial pressure (MAP). End-tidal carbon dioxide concentrations and oxygen saturations were also recorded. The changes in HR and MAP at 0, 10, 20, and 30 minutes were statistically significant between the fentanyl and control groups (P<.05). Fentanyl reduced pain scores significantly at all evaluations (P<.05). The results suggest that fentanyl preemptively decreases injection and intraoperative hyperalgesia and provides hemodynamic stability without affecting patient cooperation, resulting in cataract surgery with retrobulbar anesthesia that is comfortable for both surgeon and patient.


  • The effects of latanoprost and brimonidine on blood flow velocity of the retrobulbar vessels: a 3‐month clinical trial

    by Ümit Übeyt Inan, Sitki Samet Ermis, Aylin Yücel, Faruk Öztürk

    : Objective:  To investigate the effects of topical latanoprost 0.005% and topical brimonidine tartrate 0.2% on retrobulbar blood flow in patients with primary open‐angle glaucoma (POAG) and ocular hypertension (OHT).Methods:  Forty‐one consecutive patients with POAG and OHT were enrolled in this prospective, open‐label, randomized, parallel study. Patients received either latanoprost 0.005% or brimonidine 0.2% for 3 months. Baseline retrobulbar blood flow measurements of the ophthalmic artery, central retinal artery and temporal short posterior ciliary artery were taken using colour Doppler imaging ultrasound, concurrently with systemic blood pressure, heart rate, ocular perfusion pressure and intraocular pressure (IOP) measurements. These measurements were repeated after 3 months.Results:  Both latanoprost and brimonidine significantly reduced IOP (p < 0.05). While there was a statistically significant increase in peak systolic velocity of the ophthalmic artery, no significant change was observed in the other vessels with latanoprost treatment (p < 0.05). Topical brimonidine did not significantly alter flow velocities or resistive indices in the retrobulbar vessels after 3 months.Conclusion:  Topical latanoprost and brimonidine significantly reduced IOP in patients with POAG and OHT without causing significant haemodynamic alterations in the retrobulbar vessels.


  • The Effect of Dehydration and Fasting on Ocular Blood Flow

    by Umit Ubeyt Inan, Aylin Yücel, S Samet Ermis, Faruk Oztürk

    To investigate the effects of dehydration and fasting on retrobulbar-vessel blood velocity in healthy subjects. Twenty-eight eyes of 28 normal subjects without ocular disease were enrolled in this study. Each subject had a baseline color-Doppler imaging ultrasound of the central retinal artery, temporal short posterior ciliary arteries, and ophthalmic artery after 14 hours of religious fasting and dehydration. The first measurements were performed in the fasting conditions. The mean blood flow velocities and resistive index were measured in each artery. One month after the fasting period, color-Doppler imaging measurements were performed in nonfasting conditions. Blood pressure, heart rate, and intraocular pressure were measured before color-Doppler imaging measurements in both the fasting and nonfasting conditions. Although systolic/diastolic blood pressure, heart rate, and intraocular pressure (111.78 ± 8.18/76.42 ± 5.75 mm Hg, 71.00 ± 2.88 beats/min, and 12.71 ± 2.25 mm Hg) were higher in nonfasting conditions (112.32 ± 7.97/78.98 ± 5.50 mm Hg, 70.71 ± 2.77 beats/min, and 13.14 ± 2.62 mm Hg, respectively), differences were not statistically significant. A statistically significant increase in peak systolic velocity in the ophthalmic artery, central retinal artery, and temporal short posterior ciliary artery was noted at the second measurements. A peak systolic velocity value of 48.90 ± 14.66 cm/sec in the ophthalmic artery increased to 58.28 ± 14.65 cm/sec in the nonfasting conditions (P < 0.05). A peak systolic velocity value of 16.88 ± 4.30 cm/sec and an end diastolic velocity of 6.69 ± 2.15 cm/sec in the central retinal artery increased to 24.24 ± 6.45 cm/sec and 9.32 ± 3.08 cm/sec, respectively, was recorded in the nonfasting and nondehydration condition (P < 0.05). Peak systolic velocity measurement of 23.42 ± 6.19 cm/sec in temporal short posterior ciliary artery increased to 26.68 ± 7.52 cm/sec at the second measurement (P < 0.05). The only significant change observed in the resistive index measurements was an increase in the ophthalmic artery resistive index in the nonfasting conditions (P < 0.05). Color-Doppler measurement may vary significantly in conditions of fasting and dehydration conditions compared with hydrated conditions. Therefore, the fasting and dehydration conditions should be considered when interpreting color-Doppler imaging results and comparing different groups of diseased or healthy subjects.


  • Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents

    by Ümit Übeyt Inan, Faruk Öztürk, Süleyman Kaynak, Emin Kurt, Levent Emiroğlu, Erdener Özer, Süleyman Sami Ilker, Cenap Güler

    To determine whether an intraoperative single dose of dexamethasone, diclofenac, ethylenediaminetetraacetic acid (EDTA), a combination of EDTA and RGD peptide (arginine-glycin-aspartic acid sequence), or mitomycin-C (MMC) is a pharmacological means of preventing or reducing the development of posterior capsule opacification (PCO). Department of Ophthalmology, Celal Bayar University, School of Medicine, Manisa, and Department of Pathology, Dokur Eylül University, School of Medicine, Izmir, Turkey. Fifty-four rabbits were randomly divided into 6 groups. Dexamethasone (4 mg/cc), diclofenac (2.5 mg/cc), EDTA (8 mg/cc), a combination of EDTA and RGD peptide (2.5 mg/cc), or MMC (0.04 mg/cc) was given, 0.1 cc by hydrodissection and 0.9 cc into the capsular bag after phacoemulsification. The sixth group served as a control group. After 3 months, the PCO was graded clinically and the proliferation of lens epithelial cells (LECs) was evaluated histologically. The drugs were significantly effective in preventing PCO compared with the control (P <.005). Dexamethasone had a weaker effect than the other drugs. In histological analysis, although monolayer LECs in the dexamethasone and diclofenac groups were observed, there was no proliferative activity on the posterior capsules in the EDTA, EDTA+RGD, and MMC groups in contrast to the multilayer cells in the control. Intraoperative single-dose application of EDTA, EDTA+RGD peptide combination, and MMC significantly prevented the development of PCO in rabbit eyes. Diclofenac was less effective but also reduced PCO. Although dexamethasone did not prevent the proliferation of LECs, it decreased PCO clinically.